NO985160L - Anvendelse av interleukin-10 til fremstilling av en populasjon av suppresso - Google Patents

Anvendelse av interleukin-10 til fremstilling av en populasjon av suppresso

Info

Publication number
NO985160L
NO985160L NO985160A NO985160A NO985160L NO 985160 L NO985160 L NO 985160L NO 985160 A NO985160 A NO 985160A NO 985160 A NO985160 A NO 985160A NO 985160 L NO985160 L NO 985160L
Authority
NO
Norway
Prior art keywords
interleukin
population
suppresso
prepare
alloantigens
Prior art date
Application number
NO985160A
Other languages
English (en)
Other versions
NO985160D0 (no
Inventor
Maria-Grazia Roncarolo
Malefyt Rene De Waal
Rosa Bacchetta
Herve M Groux
Jan E De Vries
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO985160D0 publication Critical patent/NO985160D0/no
Publication of NO985160L publication Critical patent/NO985160L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Interleukin-10 for fremstil- ling av en populasjon av celler som er i stand til å inhibere eller under- trykke reaksjoner på alloantigener, f.eks. ved graft-versus-host-sykdom eller vevsavstøtning. Interleukin-10 for reduksjon av responser ved blandet lymfocyttrespons (MLR) er også be- skrevet. Eksogent eller indusert, endo- gent IL-10 kan anvendes for inhibering eller undertrykkelse av reaksjonene på alloantigener.
NO985160A 1996-05-06 1998-11-05 Anvendelse av interleukin-10 til fremstilling av en populasjon av suppresso NO985160L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/643,810 US6277635B1 (en) 1992-03-04 1996-05-06 Use of interleukin-10 to produce a population of suppressor cells
PCT/US1997/007120 WO1997042324A1 (en) 1996-05-06 1997-05-02 Use of interleukin-10 to produce a population of suppressor cells

Publications (2)

Publication Number Publication Date
NO985160D0 NO985160D0 (no) 1998-11-05
NO985160L true NO985160L (no) 1999-01-06

Family

ID=24582315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985160A NO985160L (no) 1996-05-06 1998-11-05 Anvendelse av interleukin-10 til fremstilling av en populasjon av suppresso

Country Status (16)

Country Link
US (1) US6277635B1 (no)
EP (1) EP0906428A1 (no)
JP (1) JP2000509604A (no)
KR (1) KR20000010799A (no)
AR (1) AR006942A1 (no)
AU (1) AU2927597A (no)
BR (1) BR9709307A (no)
CA (1) CA2253803A1 (no)
CZ (1) CZ347798A3 (no)
IL (1) IL126658A0 (no)
NO (1) NO985160L (no)
NZ (1) NZ332413A (no)
PL (1) PL329732A1 (no)
SK (1) SK151898A3 (no)
WO (1) WO1997042324A1 (no)
ZA (1) ZA973815B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358506B1 (en) 1997-11-05 2002-03-19 University Of Southern California Use of cytokines and mitogens to inhibit pathological immune responses
WO1999030730A1 (en) * 1997-12-15 1999-06-24 Universite Laval Methods and compositions for improving the success of cell transplantation in a host
US6803036B1 (en) 1998-03-03 2004-10-12 University Of Southern California Use of cytokines, cells and mitogens to inhibit graft versus host disease
US6447765B1 (en) 1998-03-03 2002-09-10 University Of Southern California Use of cytokines and mitogens to inhibit graft versus host disease
WO2001016296A2 (en) * 1999-09-01 2001-03-08 University Of Southern California Use of cytokines, cells, and mitogens to inhibit graft versus host disease
GB9928193D0 (en) * 1999-11-29 2000-01-26 Univ Bristol Cell treatment method
JP5008810B2 (ja) * 2000-04-11 2012-08-22 ユニバーシティ オブ サザン カリフォルニア 抑制性Ｔ細胞を誘導するためにＴＧＦ−βを用いる移植拒絶反応を防止する方法
WO2002026265A2 (en) 2000-09-29 2002-04-04 Schering Corporation Pegylated interleukin-10
FR2824567B1 (fr) 2001-05-11 2003-08-08 Inst Nat Sante Rech Med Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene
US8119401B2 (en) * 2002-03-07 2012-02-21 Amsterdam Molecular Therapeutics (Amt) Ip B.V. IL-10 gene transfer to peripheral mononuclear cells
GB0214528D0 (en) * 2002-06-24 2002-08-07 Univ Aberdeen Materials and methods for induction of immune tolerance
DK1565183T3 (da) 2002-11-29 2008-12-01 Maria Grazia Roncarolo Rapamycin og IL-10 til behandling af autoimmune sygdomme
FR2852967B1 (fr) * 2003-03-26 2007-12-07 Txcell Procede d'obtention de cellules dendritiques et de cellules t
FR2856700B1 (fr) * 2003-06-24 2007-06-08 Txcell Procede d'identification de lymphocytes tr1 regulateurs par la presence et la surexpression de molecules specifiques et ses applications
EP2591786B1 (en) 2003-10-16 2017-04-12 Cancure Limited Immunomodulating compositions and uses therefor
CA2545841A1 (en) * 2003-11-12 2005-05-26 Txcell Use of lipopeptides for activating t lymphocytes through the skin
JP4863452B2 (ja) * 2006-03-30 2012-01-25 国立大学法人 千葉大学 ヒトＴｈ１／Ｔｈ２分化誘導系及びその用途
WO2007131575A1 (en) * 2006-05-12 2007-11-22 Fondazione Centro San Raffaele Del Monte Tabor Tolerogenic dendritic cells, method for their production and uses thereof
WO2010101870A1 (en) 2009-03-03 2010-09-10 St. Jude Children's Research Hospital Compositions and methods for generating interleukin-35-induced regulatory t cells
US10143778B2 (en) * 2010-12-21 2018-12-04 Cormatrix Cardiovascular, Inc Cardiovascular prostheses
CA2877286C (en) 2012-06-18 2023-05-16 Yale University Compositions and methods for diminishing an immune response
CA2782942C (en) * 2012-07-12 2019-08-27 Canadian Blood Services Method for inducing immune tolerance using polymer-modified antigenic leukocytes
US11007221B2 (en) 2013-07-12 2021-05-18 Canadian Blood Services Acellular pro-inflammatory compositions, process for making same and methods of using same
KR101868950B1 (ko) 2017-05-18 2018-06-19 연세대학교 산학협력단 Ｉｌ－１０을 발현하는 신경줄기세포를 포함하는 중추 신경계 질환 또는 손상의 치료용 약학적 조성물 및 이를 이용한 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483920A (en) 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
US4559310A (en) 1983-05-20 1985-12-17 Dana Farber Cancer Institute Assay methods and systems utilizing mast cell clones
IL94878A (en) 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
JP2000509604A (ja) 2000-08-02
SK151898A3 (en) 2000-04-10
ZA973815B (en) 1997-11-03
IL126658A0 (en) 1999-08-17
KR20000010799A (ko) 2000-02-25
WO1997042324A1 (en) 1997-11-13
BR9709307A (pt) 1999-08-10
AR006942A1 (es) 1999-09-29
CZ347798A3 (cs) 1999-03-17
AU2927597A (en) 1997-11-26
PL329732A1 (en) 1999-04-12
NZ332413A (en) 2000-10-27
EP0906428A1 (en) 1999-04-07
NO985160D0 (no) 1998-11-05
CA2253803A1 (en) 1997-11-13
US6277635B1 (en) 2001-08-21

Similar Documents

Publication Publication Date Title
NO985160L (no) Anvendelse av interleukin-10 til fremstilling av en populasjon av suppresso
DE69524624D1 (de) Saponinzubereitungen und deren verwendung in iscoms
ES2161875T3 (es) Celulas con multiples epitopos alterados en un antigeno superficial para uso en transplantes.
CA2250078A1 (en) Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
JPS57500830A (no)
DE69737496D1 (de) SIALYL-LEWISa UND SIALYL LEWISx EPITOP-ANALOGE
ES520985A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
IT8422580A0 (it) Composizioni che le contengono e proteine di membrana cellulare, procedimento per prepararle.
NO992282L (no) Benzonaftyridiner som bronkialterapentika
AU1577695A (en) Nucleic acid transfection efficiency increase by use of isopropanol in aqueous solutions
ES2101896T3 (es) Zeolita basada en un aluminosilicato politipo hexagonal de la faujasita.
DK45078A (da) Fremgangsmaade til fremstilling af metalcarbonylaggregater immobiliseret i zeolitter og deres anvendelse som heterogene kattalysatorer
AU6101590A (en) Halogenoalkylphenyl-alcohols, -keytones and hydrates thereof
CA2061995A1 (en) Use of oxime ether derivatives for bioregulation in plants
DK313587A (da) Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse
DK0765398T3 (da) Population af celler, der er beriget for myeloide og/eller lymfoide progenitorer og fremgangsmåde til fremstilling og anvendelse deraf
ATE106899T1 (de) Inhibitor der proliferation von endothelzellen.
AU2550092A (en) A device for securing two or more seismic energy sources at fixed relative positions
ES483830A2 (es) Perfeccionamientos en el objeto de la patente 473.523 por metodo de produccion de levadura de panaderia y similares
JPS6485990A (en) Antihypertestoeronemia agent
DK0417875T3 (da) 1-methoxypyrimidinyl-1H-1,2,4-triazol-3-sulfonsyrenitroanilider, fremgangsmåde til fremstilling heraf og deres anvendelse som middel med herbicid virkning
DK382183A (da) I 6-stilling usubstituerede 7-oxo-4-oxa-diazabicyclo(3.2.0)hept-2-en-derivater, fremgangsmaader til deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af beta-lactamantibiotika
NO875066L (no) Preparater som er anvendelige ved tomodensitometri.
NO880479D0 (no) Smaa peptider som hindrer binding til t4-reseptorer og virker som immunorganer, fremgangsmaaten til deres fremstilling og anvendelse av slike peptider.
JPS5765181A (en) Heat-resistant adenylate kinase and its preparation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application